All cardiovascular death · patients of any age with AAA less than 30 mm in diameter
Metoprolol showed no clear difference in cardiovascular death, 30 days3 compared with placebo (low certainty).
1 finding from 1 review
AAA‐related death, 30 days4 · patients of any age with AAA less than 30 mm in diameter
Metoprolol showed no clear difference in AAA‐related death, 30 days4 compared with placebo (low certainty).
1 finding from 1 review
Nonfatal cardiovascular event, 30 days5 · patients of any age with AAA less than 30 mm in diameter
Metoprolol showed no clear difference in nonfatal cardiovascular event, 30 days5 compared with placebo (low certainty).
1 finding from 1 review
Length of hospital stay · children with pleural empyema
1 finding from 1 review
Length of hospital stay · children and adults with pleural empyema
1 finding from 1 review
Intervention not reported
Serum creatinine: day 1 · patients undergoing a surgical intervention that induces kidney injury
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Serum creatinine: day 2 · patients undergoing a surgical intervention that induces kidney injury
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Serum creatinine: day 3 · patients undergoing a surgical intervention that induces kidney injury
1 finding from 1 review
no estimate extracted
Studies not reported
High
Time away from normal activities (days) · patients with recurrence and pain in Lichtenstein inguinal hernioplasty
1 finding from 1 review
Mortality at 28 days · adult patients with sepsis, severe sepsis and septic shock
PCT showed no clear difference in mortality at 28 days compared with non‐PCT (standard care or CRP: primary outcomes) (low certainty).
1 finding from 1 review
Time receiving antimicrobial therapy (days) ‐ mean (SD) · adult patients with sepsis, severe sepsis and septic shock
1 finding from 1 review
Participants who required surgical incision and drainage after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participants experiencing the occurrence of a chalazion after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participants with a secondary hordeolum during or after the treatment period and seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Resolution of hordeolum between 8 and 30 days after diagnosis, or that closest to 14 days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participants who required surgical incision and drainage after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participants experiencing the occurrence of a chalazion after the treatment period or seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Resolution of hordeolum between 8 and 30 days after diagnosis, or that closest to 14 days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Participants with a secondary hordeolum during or after the treatment period and seven days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review
Resolution of hordeolum between 8 and 30 days after diagnosis, or that closest to 14 days after diagnosis · people with acute hordeolum
The review found no eligible studies for this question.
1 finding from 1 review